
Sign up to save your podcasts
Or


Do you know how to select the optimal treatment for a patient with early breast cancer who is eligible for PARP inhibitor and CDK4/6 inhibitor therapy? Credit available for this activity expires: 3/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990176?ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2525 ratings
Do you know how to select the optimal treatment for a patient with early breast cancer who is eligible for PARP inhibitor and CDK4/6 inhibitor therapy? Credit available for this activity expires: 3/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990176?ecd=bdc_podcast_libsyn_mscpedu

139 Listeners

699 Listeners

499 Listeners

169 Listeners

102 Listeners

884 Listeners

13 Listeners

17 Listeners

291 Listeners

260 Listeners

3,348 Listeners

1,156 Listeners

196 Listeners

90 Listeners

512 Listeners

363 Listeners

172 Listeners

60 Listeners

8 Listeners

427 Listeners